Home Cart Sign in  
Chemical Structure| 4674-50-4 Chemical Structure| 4674-50-4

Structure of (+)-Nootkatone
CAS No.: 4674-50-4

Chemical Structure| 4674-50-4

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Nootkatone is a natural organic compound, used as insecticide and food additive.

Synonyms: Nootkatone

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Product Citations

Krueger, Nadine ; Kronenberger, Thales ; Xie, Hang ; Rocha, Cheila ; Poehlmann, Stefan ; Su, Haixia , et al.

Abstract: The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has forced the development of direct-acting antiviral drugs due to the coronavirus disease 2019 (COVID-19) pandemic. The main protease of SARS-CoV-2 is a crucial enzyme that breaks down polyproteins synthesized from the viral RNA, making it a validated target for the development of SARS-CoV-2 therapeutics. New chem. phenotypes are frequently discovered in natural goods. In the current study, we used a fluorogenic assay to test a variety of natural products for their ability to inhibit SARS-CoV-2 Mpro. Several compounds were discovered to inhibit Mpro at low micromolar concentrations It was possible to crystallize robinetin together with SARS-CoV-2 Mpro, and the X-ray structure revealed covalent interaction with the protease's catalytic Cys145 site. Selected potent mols. also exhibited antiviral properties without cytotoxicity. Some of these powerful inhibitors might be utilized as lead compounds for future COVID-19 research.

Keywords: COVID-19 ; antivirals ; coronavirus ; covalent drugs ; dynamic light scattering ; inhibitors ; main protease ; natural products

Alternative Products

Product Details of (+)-Nootkatone

CAS No. :4674-50-4
Formula : C15H22O
M.W : 218.33
SMILES Code : O=C1C=C2CC[C@@H](C(C)=C)C[C@@]2(C)[C@H](C)C1
Synonyms :
Nootkatone
MDL No. :MFCD04974578
InChI Key :WTOYNNBCKUYIKC-JMSVASOKSA-N
Pubchem ID :1268142

Safety of (+)-Nootkatone

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
Raw264.7 cells 50 μM Activated HO-1 protein expression, inhibited LPS-induced iNOS protein expression, NO production, and HMGB1 release Antioxidants (Basel). 2023 Feb 3;12(2):370
GL261 cells 100 µM, 200 µM, 300 µM NKT significantly inhibited the growth of GL261 cells in a concentration-dependent manner. Mol Med. 2025 Jan 16;31(1):13
U251 cells 100 µM, 200 µM, 300 µM 24 to 48 h NKT significantly inhibited the growth of U251 cells in a dose- and time-dependent manner. Mol Med. 2025 Jan 16;31(1):13
C6 cells 100 µM, 200 µM, 300 µM 24 to 48 h NKT significantly inhibited the growth of C6 cells in a dose- and time-dependent manner. Mol Med. 2025 Jan 16;31(1):13

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
C57BL/6 mice CCl4-induced nephrotoxicity model Oral 5, 10, and 20 mg/kg/day 7 consecutive days Significantly attenuated CCl4-induced increases in serum BUN and CRE levels and kidney pathological injury, inhibited oxidative stress, inflammatory response, and activation of caspases-9/-3, downregulated NOX4, IL-1β, IL-6, and TNF-α protein expression and NO levels, and upregulated Nrf2 and HO-1 mRNA expression Antioxidants (Basel). 2023 Feb 3;12(2):370
C57BL/6 mice GBM orthotopic mouse model Intraperitoneal injection 40 mg/kg Once daily for two weeks NKT significantly inhibited tumor growth in the GBM orthotopic mouse model and extended the survival time of mice. Mol Med. 2025 Jan 16;31(1):13
C57BL/6J mice Unilateral ureteral obstructive (UUO) model Oral 10 mg/kg Once daily for 14 or 28 days To investigate the protective effects of Nootkatone on renal inflammation, apoptosis, and fibrosis in a UUO mouse model. Results showed that Nootkatone treatment significantly alleviated pathological changes, collagen deposition, oxidative stress injury, inflammatory cell infiltration, and renal cell apoptosis. Nutrients. 2021 Nov 1;13(11):3921
BALB/C mice Diesel exhaust particles (DEP)-induced lung injury model Gavage 90 mg/kg Single dose, 1 hour before DEP exposure To evaluate the protective effects of nootkatone on DEP-induced lung toxicity and its mechanisms. Nootkatone pretreatment significantly prevented the DEP-induced increase in airway resistance, decreased neutrophil infiltration in bronchoalveolar lavage fluid, and reduced macrophage and neutrophil infiltration in the lung interstitium. It also alleviated oxidative stress, DNA damage, and apoptosis by inhibiting NF-κB activation. Nutrients. 2018 Feb 26;10(3):263
Sprague Dawley rats MM-induced nephrotoxicity model Oral 5 and 10 mg/kg Consecutive 28 days To evaluate the renoprotective effect of NK against MM-induced renal damage. Results showed NK significantly reduced renal functional parameters, oxidative stress, inflammatory and apoptotic markers, and improved renal histopathological features. Drug Des Devel Ther. 2024 Jul 16;18:2989-3004
C57BL/6 mice MPTP-induced Parkinson's disease mouse model Intraperitoneal injection 2 or 5 mg/kg Three consecutive days, once daily NKT ameliorated MPTP-induced motor impairment and dopaminergic neuronal loss and inhibited astrocyte and microglial activation. Antioxidants (Basel). 2023 Nov 13;12(11):1999

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

4.58mL

0.92mL

0.46mL

22.90mL

4.58mL

2.29mL

45.80mL

9.16mL

4.58mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories